Wells Fargo Maintains Overweight on Boston Scientific, Raises Price Target to $72
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Larry Biegelsen maintains an Overweight rating on Boston Scientific (NYSE:BSX) and raises the price target from $70 to $72.
February 01, 2024 | 1:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wells Fargo maintains an Overweight rating on Boston Scientific and raises the price target to $72.
The upgrade in the price target by a reputable analyst like Larry Biegelsen suggests a positive outlook on Boston Scientific's stock, likely leading to increased investor confidence and potentially a short-term rise in the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100